Replies to post #122029 on Anavex Life Sciences Corp (AVXL)

[Gernee20]

Less then a month ago the company just presented at a partnering conference where MS was part of there presentation regarding moving 2-73 from preclinical to clinical in the MS indication. Why on earth would they do that if MS was a no go?

[ExtremelyBullishZig]

Most likely delaying 104 week updates to give us something once we go silent on 2018 waiting for blinded trials to end.